Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 23, 2011
The associations among coping, nadir CD4+ T-cell count, and non-HIV-related variables with health-related quality of life among an ambulatory HIV-positive patient populationCarl Armon, Kenneth Lichtenstein
Antiviral Therapy|April 26, 2003
Adipocyte-derived hormone levels in HIV lipodystrophyLisa Kosmiski, Daniel Kuritzkes, Kenneth Lichtenstein, et al.
AIDS Research and Therapy|July 20, 2007
HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impactKenneth Lichtenstein, Ashok Balasubramanyam, Rajagopal Sekhar, et al.
AIDS Research and Therapy|June 29, 2007
HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanismsKenneth Lichtenstein, Ashok Balasubramanyam, Rajagopal Sekhar, et al.
The Clinical Journal of Pain|May 5, 2011
Factors associated with initiation of prolonged analgesic use among patients in the HIV Outpatient Study (HOPS)John Koeppe, Kenneth Lichtenstein, Carl Armon, et al.
AIDS (London, England)|April 12, 2005
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failuresMargaret Johnson, Beatriz Grinsztejn, Claudia Rodriguez, et al.
AIDS (London, England)|March 4, 2006
96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failuresMargaret Johnson, Beatriz Grinsztejn, Claudia Rodriguez, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudineJoseph E Rower, Amie Meditz, Edward M Gardner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 3, 2015
Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 StudyAnton Pozniak, Jose R Arribas, Joseph Gathe, et al.
The Lancet. HIV|January 27, 2019
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studiesKeri N Althoff, Kelly A Gebo, Richard D Moore, et al.
Pageof 1